Asia | Surviving Mesothelioma

Thoracoscopy Deemed “Valuable and Safe” for Mesothelioma Patients

Pleural mesothelioma patients who are recommended for medical thoracoscopy can rest assured that the procedure is “a valuable and safe” diagnostic tool. That is the message from Chinese researchers after an analysis of nine years of medical thoracoscopies on more than 800 patients with malignant mesothelioma and other pleural cancers at a Beijing hospital. What is Medical Thoracoscopy? Medical thoracoscopy is a minimally invasive procedure … Continue reading Thoracoscopy Deemed “Valuable and Safe” for Mesothelioma Patients »

Compound in Broccoli May Enhance Mesothelioma Treatment with Cisplatin

There is new evidence that a compound found in cruciferous vegetables like broccoli and cabbage may enhance the anticancer benefits of the platinum-based drug cisplatin in the treatment of pleural mesothelioma. Although malignant mesothelioma is highly resistant to conventional cancer treatments, most mesothelioma patients will receive chemotherapy with cisplatin and pemetrexed (Alimta) as part of a multi-modal approach to treatment. Now, researchers Yoon-Jin and Sang-Han … Continue reading Compound in Broccoli May Enhance Mesothelioma Treatment with Cisplatin »

The Influence of BAP1 on Mesothelioma Survival

A mutation on the BAP1 tumor suppressor gene can influence the development of malignant mesothelioma but may have little bearing on survival. That conclusion comes from a new Chinese study of more than 2,400 people with cancers directly linked to the BAP1 genetic mutation, including pleural mesothelioma. BAP1 and Mesothelioma BRCA1-associated protein 1 (BAP1) is a tumor suppressing protein encoded by the BAP1 gene. Multiple studies … Continue reading The Influence of BAP1 on Mesothelioma Survival »

Cholesterol Drug May Protect Mesothelioma Patients from Radiation

A new study suggests that the cholesterol-lowering drug pravastatin could one-day be used to help protect mesothelioma patients from the damaging side effects of radiotherapy. According to Japanese researchers, mice with malignant mesothelioma who were given pravastatin (Pravachol) in drinking water prior to receiving radiation experienced less damage to healthy cells in their lungs and intestines. The results suggest that pravastatin might make radiotherapy safer … Continue reading Cholesterol Drug May Protect Mesothelioma Patients from Radiation »

Predicting Mesothelioma Outcomes with Soluble Mesothelin

New research suggests that a protein often used to help diagnose and track malignant mesothelioma may also be a valuable prognostic indicator. Soluble mesothelin-related protein (SMRP) is a biomarker for pleural mesothelioma, an aggressive asbestos-linked cancer that causes few symptoms until in its late stages. The presence of SMRP in the blood indicates that mesothelial cells on the lining around the lungs have been damaged. … Continue reading Predicting Mesothelioma Outcomes with Soluble Mesothelin »

Additional Chemotherapy Extends Survival in Relapsed Mesothelioma Patients

Black American Patient

Mesothelioma patients who experience a recurrence of their asbestos cancer after radical surgery may live longer if they undergo additional rounds of chemotherapy. That conclusion comes from a group of Japanese researchers who performed a retrospective review of 59 consecutive pleural mesothelioma patients who had multimodal mesothelioma treatment that included extrapleural pneumonectomy (EPP) surgery. Study subjects had been treated for malignant mesothelioma at Hyogo College … Continue reading Additional Chemotherapy Extends Survival in Relapsed Mesothelioma Patients »

More Evidence for Inflammation Marker in Mesothelioma Prognosis

There is more evidence that a measure of how well the immune system is functioning may be an efficient prognostic tool for people with malignant pleural mesothelioma. Even though some recent studies have found the ratio of neutrophils to lymphocytes (NLR) in the blood to be a poor prognostic indicator for cancer, Chinese researchers say it may still be effective for planning mesothelioma treatment and qualifying … Continue reading More Evidence for Inflammation Marker in Mesothelioma Prognosis »

Mesothelioma Patients May Need Special Help After Surgery

Pleural mesothelioma patients who undergo pleurectomy/decortication (P/D) surgery may need customized rehabilitation strategies to help restore their quality of life. That is the finding of a Japanese study conducted by rehabilitation experts at the Hyogo College of Medicine. In a study of malignant pleural mesothelioma patients, the team found that, after P/D, many measures of physical strength and vitality decreased, along with their health-related quality … Continue reading Mesothelioma Patients May Need Special Help After Surgery »

The Impact of Nutritional Status on Mesothelioma Survival

There is new evidence that a mesothelioma patient’s nutritional status could have an impact on their treatment outcomes. A group of Japanese surgeons, oncologists and pathologists compared the treatment responses of 83 patients with pleural mesothelioma and found that patients with the poorest nutritional status tended to have the poorest mesothelioma prognosis. Controlling Nutritional Status Score To reach their conclusion, the researchers used a tool … Continue reading The Impact of Nutritional Status on Mesothelioma Survival »

Novel Technique Controls Pleural Effusion in Mesothelioma Patients

Japanese researchers have come up with a new method of controlling one of the most bothersome and life-limiting symptoms of late stage malignant mesothelioma – a buildup of fluid around the lungs called malignant pleural effusion. When fluid collects in the space between the layers of the pleural membrane around the lungs, it becomes more difficult for the lungs to expand properly. At this stage, … Continue reading Novel Technique Controls Pleural Effusion in Mesothelioma Patients »

Get your free copy of
“Surviving Mesothelioma” Today!